IMMR
Immersion Corporation
IMMR has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over IMMR overall, supported by stronger fundamentals and stronger valuation.
IMMR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Strong |
IMMR's balance sheet is currently strong, and its revenue, profitability and cash flow are stable.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
IMMR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 2.8x | $0.95 | -86% |
| Fair | 7.4x | $2.51 | -64% |
| Expensive | 20x | $6.92 | -0.7% |
| Current | 21x | $6.97 | — |
Historical ranges are pointers, not guarantees.
IMMR's PE is in its expensive range at 21x.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK has the edge over IMMR in the historical PE scenario, which offers more potential upside but is not a forecast.
IMMR Forward outlook
There aren't enough analyst estimates for IMMR to show an outlook.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
IMMR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.34 | -51% |
| Q1 2024 | $1.38 | +35% |
| Q4 2023 | $1.04 | +13% |
| Q3 2023 | $1.13 | +214% |
| Q2 2023 | $1.28 | +412% |
| Q1 2023 | $1.02 | +117% |
| Q4 2022 | $0.92 | +136% |
| Q3 2022 | $0.36 | -43% |
IMMR's earnings per share have fallen from their peak: $0.34 over the past year, against $1.38 in early 2024.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over IMMR in the latest year-over-year earnings comparison.
IMMR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $294.4M | +0.8% |
| Q2 2026 | $270M | -5.2% |
| Q1 2026 | $518.5M | +9.2% |
| Q4 2025 | $650.2M | +5.5% |
| Q3 2025 | $292M | +194% |
| Q2 2025 | $284.9M | +522% |
| Q1 2025 | $474.8M | +4474% |
| Q4 2024 | $616.2M | +6399% |
IMMR has the edge over SNDK on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -6.8% | +2.2 points |
| Q2 2026 | 2.7% | +3.1 points |
| Q1 2026 | 1% | -4.6 points |
| Q4 2025 | 6.2% | -4.3 points |
| Q3 2025 | -9% | -35 points |
| Q2 2025 | -0.4% | -35 points |
| Q1 2025 | 5.5% | -32 points |
| Q4 2024 | 10% | -38 points |
IMMR's operating margin was −6.8% last quarter, up 2.2 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK's revenue has grown year over year for six quarters in a row: $11B last quarter, up 378% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over IMMR on profitability, with a higher operating margin.
IMMR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$47.1M | +$18.3M |
| Q2 2026 | $79.4M | +69% |
| Q1 2026 | -$37.5M | +$8.8M |
| Q2 2025 | $47M | +49% |
| Q1 2025 | -$46.2M | -691% |
| Q2 2024 | $31.6M | +797% |
| Q1 2024 | $29.9M | +749% |
| Q4 2023 | $7.8M | -3% |
IMMR has the edge over SNDK on cash flow, with more consistent year-over-year improvement.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK generated $17.4B in free cash flow over the past year, more than ten times what it generated the year before.
IMMR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +176K shares |
| 1 year | +2.1% | +688K shares |
| 3 years | +1.7% | +553K shares |
| 5 years | +6.6% | +2.1M shares |
| Available history | +4.4% | +1.4M shares |
IMMR has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2023 | $2.1M |
| Q3 2023 | $3.3M |
| Q2 2023 | $2.9M |
| Q1 2023 | — |
| Q4 2022 | $2M |
| Q3 2022 | $5.2M |
| Q2 2022 | $1.6M |
| Q1 2022 | $4.4M |
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
IMMR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.3x | Net Cash |
| Q2 2026 | -1.0x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -1.6x | Net Cash |
| Q1 2024 | -2.9x | Net Cash |
| Q4 2023 | -3.1x | Net Cash |
| Q3 2023 | -1.5x | Net Cash |
| Q2 2022 | -3.2x | Net Cash |
IMMR has the edge over SNDK on leverage, with a lower net debt burden relative to earnings.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
IMMR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.0 | Neutral |
| Stochastic | 26.0 | Neutral |
IMMR's weekly RSI is 49 (neutral) and its Stochastic is 26 (neutral).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
IMMR PE vs Technology Sector
| Metric | IMMR | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 26% below |
| PE % | 84 | 35 | 49 pts above |
IMMR is trading at 21x earnings, a 26% discount to the Technology sector's median of 28x.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over IMMR on valuation relative to its sector.
IMMR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.14 | 2.4% below |
| 20 week MA | $7.20 | 3.2% below |
| 50 week MA | $6.70 | 4% above |
| 100 week MA | $7.11 | 2% below |
| 200 week MA | $7.51 | 7.2% below |
IMMR has stronger trend alignment. IMMR is above 1 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
IMMR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.58 | $8.93 | +18% |
| 2021 | $8.93 | $6.10 | -32% |
| 2022 | $6.10 | $7.33 | +20% |
| 2023 | $7.33 | $7.06 | -3.7% |
| 2024 | $7.06 | $9.00 | +27% |
| 2025 | $9.00 | $6.85 | -24% |
| 2026 YTD | $6.85 | $6.97 | +1.8% |
IMMR has finished lower in three of the last six years. It's up 1.8% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over IMMR on returns for 2026, with the stronger performance.